To get in touch with us and schedule your consultation, please fill out the form below or give us a call at (805) 544-5567
In these neurons, the presence of GLP-1 signifies mechanical distension in the gut, signalling the neurons to facilitate increases in gastric pressure which is needed for normal digestion and may explain other gastrointestinal side-effects such as diarrhea
Weight Loss Distribution The results weren't just impressive on averagethey were consistent across the patient population: Weight Loss Thresholds Achieved (12mg dose): 5% weight loss: 94.6% of participants 10% weight loss: 91.3% of participants 15% weight loss: 83.2% of participants 20% weight loss: 73.4% of participants 25% weight loss: 58.6% of participants For comparison, FDA approval for obesity medications typically requires that at least 35% of patients achieve 5% weight loss
An electrolyte powder or oral rehydration drink, sipped through the day, can help
We are living through something unprecedented, not because the drugs are new, but because proven science now meets mass accessibility and cultural momentum
Mechanism and Broader Clinical Context Semaglutide is a GLP-1 receptor agonist that enhances insulin secretion, reduces glucagon levels, and slows gastric emptying, contributing to improved blood glucose control